ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma
Clinical trial NCT01997840 · TERMINATED
Trial details
- NCT number
- NCT01997840
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2024-02-29
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.